Spots Global Cancer Trial Database for Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.
Official Title: Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors: a Prospective Randomized Controlled Study.
Study ID: NCT05072327
Conditions
Study Description
Brief Summary: This study aim to investigate whether the prognosis of eyelid malignant tumor is better treated with Mohs surgery combind with cryotherapy than Mohs surgery only.
Detailed Description: This study is a randomized perspective study. American Joint Committee on Cancer was applied to define the cancer stage of patients recruited. Patients with Tis to T3cN0M0 will be randomized to receive Mohs surgery or Mohs suregery conbind cryotherapy. Patients will be followed for 3 years.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China
Contact Details
Name: Huasheng Yang, Doctor
Affiliation: Zhongshan Ophthalmic Center, Sun Yat-sen University
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
